Barclays Maintains Overweight on JBS, Raises Price Target to $23

Barclays analyst Benjamin Theurer has maintained an Overweight rating on JBS (NYSE: JBS) and raised the price target from $22 to $23. This adjustment reflects a positive outlook on the company's performance.